ID   TN922
AC   CVCL_RM20
DR   Wikidata; Q54972722
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10226566;
CC   Population: Japanese.
CC   Doubling time: ~36 hours (PubMed=10226566).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
RX   PubMed=10226566;
RA   Nakayama, Takashi
RA   Tohyama, Kaoru
RA   Imamura, Shin
RA   Yoshida, Akira
RA   Fukushima, Toshihiro
RA   Tsutani, Hiroshi
RA   Nakamura, Toru
RA   Wano, Yuji
RA   Ohno, Yohichiro
RA   Ueda, Takanori
RT   "A novel Philadelphia chromosome-positive cell line with
RT   multipotential properties.";
RL   Anticancer Res. 19:349-356(1999).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//